Cntr. for Clinical and Basic Research, Ballerup
Recent findings in osteoporosis described
Published in Nursing Home and Elder Business Week, May 1st, 2005
Study 1: Effective doses of ibandronate don't affect postmenopausal women's risk of cardiovascular disease by altering vascular calcification, according to a study from Denmark.
"Animal experiments revealed conflicting results as to the impact of bisphosphonate treatment on atherosclerosis and related vascular calcification. The effect of long-term treatment with clinical doses of bisphosphonates on aortic calcification (AC) in an 'at-risk' population of osteoporotic elderly women has not been assessed systematically," said Laszlo B. Tanko and colleagues,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week
More Articles from Nursing Home and Elder Business Week
- Anodyne Therapy, LLC
Study demonstrates restoration of sensation in peripheral neuropathy - Chinese University of Hong Kong
Findings advance knowledge in SARS research - Finance
Bridge Healthcare provides $7.5M to neuroscience, orthopedic hospital - Hispanic Federation
New York minority advocates, legislators condemn proposed preferred drug program - Hospital Clinic Porto Alegre
HRT doesn't affect 24-hour heart rate variability in postmenopausal women - NPS Pharmaceuticals, Inc.
Data analysis indicates parathyroid hormone improves bone microarchitecture - More from this issue of Nursing Home and Elder Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
